SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-23-015992
Filing Date
2023-12-07
Accepted
2023-12-07 20:30:14
Documents
2
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 form3a-12082023_011208.html 3/A  
1 form3a-12082023_011208.xml 3/A 1762
2 ex24-12082023_011209.htm EX-24 7427
  Complete submission text file 0001415889-23-015992.txt   10553
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

IRS No.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address
Zojwalla Naseem (Reporting) CIK: 0001905871 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39712 | Film No.: 231473764